Kalaris Therapeutics Inc (KLRS)

6.90

0.20 (2.99%)

At close: Apr 28, 2025, 3:59 PM

6.50

-5.80%

After-hours: Apr 28, 2025, 04:10 PM EDT

2.99% (1D)

Bid	6.5
Market Cap	129.05M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	-2.71
PE Ratio (ttm)	-2.55
Forward PE	n/a
Analyst	n/a

Ask	6.65
Volume	56,486
Avg. Volume (20D)	29,262
Open	6.61
Previous Close	6.70
Day's Range	6.49 - 7.31
52-Week Range	5.87 - 24.15
Beta	0.00

About KLRS

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems....

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Jul 30, 2020

Employees 14

Stock Exchange NASDAQ

Ticker Symbol KLRS

Website https://kalaristx.com/

Full Company Profile